All News

A recent article published by FiveThirtyEight (1) was highlighted on major news networks across the US, bringing attention to a very important issue facing the cannabis industry: how much tetrahydrocannabinol (THC) is actually in products. Here, we highlight some of the findings from the FiveThirtyEight report and what it means for the cannabis industry.

A letter from Group Editorial Director, Megan L'Heureux, highlighting COVID-19 research, the announcement of Cannabis Science and Technology®'s partnership with Havas ECS, and the launch of our sister publication, Cannabis Patient Care™.

The Dental College of Georgia (DCG) and the Medical College of Georgia, recently performed a study which produced results showing that cannabidiol (CBD), a non-psychoactive cannabinoid found in cannabis, reduces damage in the lungs spurred by cytokine storms caused by coronavirus (COVID-19).